Suraksha Diagnostic IPO: The subscription window for the Suraksha Diagnostic IPO closes today. Check the subscription status, GMP, listing schedule, and more

Suraksha Diagnostic IPO closes today: GMP remains flat; Should you bid?

Business Standard

Indian markets

Market LIVE: Overnight in the US, Wall Street's major indices, Nasdaq and S&P 500, closed at record highs on Monday, boosted by tech-related shares following strong November gains

Stock Market LIVE: Markets at day's high; Sensex 650 pts ahead at 80,900; Nifty at 24,450; PSB leads

Market, BSE, NSE, NIfty, Stock Market, investment

The uptick in Can Fin Homes' share price came ahead of the ex-date following the company's announcement of a dividend of Rs 6 per share for its shareholders

Can Fin Homes shares gain over 2% ahead of ex-dividend date; details

Shrem Infra Invest Pvt consolidated net profit declines 24.60% in the September 2024 quarter

Capital Market Automatic


At 13:28 IST, the barometer index, the S&P BSE Sensex was up 531.36 points or 0.66% to 80,779.44. The Nifty 50 index added 147.95 points or 0.61% to 24,421.05.


Sensex jumps 531 pts; European mkt opens higher

solar panel

Tata Power Shares: The Tata Power scrip rose after the company announced that its unit, Tata Power Renewable Energy, has successfully commissioned the 431 MW DC solar project at Neemuch in Madhya Pradesh

Tata Power rises 3% as subsidiary commissions 431 MW DC solar project in MP

Rohan Verma's departure as CEO to set up a new venture could create a leadership vacuum, according to analysts

MapmyIndia slips 12% in 2 days as Rohan Verma exits as CEO to float new co

C E Info Systems dropped 8.34% to Rs 1548.40, extending losses after the company said it will buy stake in a B2C company floated by its CEO Rohan Verma.

C E Info Systems extends losses on B2C business spin-off plan

Zydus Lifesciences Ltd is quoting at Rs 984.6, up 1.03% on the day as on 12:49 IST on the NSE. The stock is up 55.45% in last one year as compared to a 18.09% gain in NIFTY and a 38.64% gain in the Nifty Pharma index.

Zydus Lifesciences Ltd spurts 1.03%, rises for third straight session

Natco Pharma Ltd is quoting at Rs 1429.95, up 1.05% on the day as on 12:49 IST on the NSE. The stock is up 80.52% in last one year as compared to a 18.09% gain in NIFTY and a 38.64% gain in the Nifty Pharma index.

Natco Pharma Ltd soars 1.05%, Gains for third straight session

Companies News: Get latest company news, company results, company interviews, company financials, company analysis, company disclosure, corporate news, company announcements at Business Standard.

Company News: Company Business News, Indian Companies News, Company Analysis, Corporate Industry News

Get latest company news, company results, company interviews, company financials, company analysis, company disclosure, corporate news, company announcements at Business Standard.

Bentley Commercial Enterprises Ltd News